L
Lukas Bestmann
Researcher at University of Zurich
Publications - 23
Citations - 1494
Lukas Bestmann is an academic researcher from University of Zurich. The author has contributed to research in topics: Lymphocytic choriomeningitis & Virus. The author has an hindex of 16, co-authored 22 publications receiving 1417 citations. Previous affiliations of Lukas Bestmann include University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
Karine Julier,Rafaela F. da Silva,Carmen García,Lukas Bestmann,Philippe Frascarolo,Andreas Zollinger,Pierre-Guy Chassot,Edith R. Schmid,Marko Turina,Ludwig K. von Segesser,Thomas Pasch,Donat R. Spahn,Michael Zaugg +12 more
TL;DR: Sevoflurane preconditioning preserves myocardial and renal function as assessed by biochemical markers in patients undergoing coronary artery bypass graft surgery under cardioplegic arrest.
Journal ArticleDOI
Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery
Carmen García,K. Julier,Lukas Bestmann,Andreas Zollinger,L.K. von Segesser,T. Pasch,Donat R. Spahn,Michael Zaugg +7 more
TL;DR: Evidence of a protective role for pharmacological preconditioning by sevoflurane in late cardiac events in CABG patients, which may be related to favourable transcriptional changes in pro- and antiprotective proteins, is provided.
Journal ArticleDOI
Remote ischemic preconditioning applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass graft surgery: lack of synergy or evidence of antagonism in cardioprotection?
Eliana Lucchinetti,Lukas Bestmann,Jianhua Feng,Heike Freidank,Alexander S. Clanachan,Barry A. Finegan,Michael Zaugg +6 more
TL;DR: RIPC applied during isoflurane inhalation provides no benefit to the myocardium of patients undergoing on-pump coronary artery bypass grafting and there was no difference in the 6-month cardiovascular outcome.
Journal ArticleDOI
Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up
Michael Zaugg,Lukas Bestmann,Johannes Wacker,Eliana Lucchinetti,Anita Boltres,Christian Schulz,Martin Hersberger,Gabriela Kälin,Lukas Furrer,Christoph K. Hofer,Stephan Blumenthal,Annabelle Müller,Andreas Zollinger,Donat R. Spahn,Alain Borgeat +14 more
TL;DR: Perioperative bisoprolol therapy did not affect cardiovascular outcome in these elderly at-risk patients undergoing surgery with spinal block, and carriers of at least one Gly allele of the β1-adrenergic receptor polymorphism Arg389Gly showed a higher number of adverse events.
Journal ArticleDOI
T cell-dependence of Lassa fever pathogenesis
Lukas Flatz,Lukas Flatz,Toni Rieger,Doron Merkler,Andreas Bergthaler,Andreas Bergthaler,Tommy Regen,Mariann Schedensack,Lukas Bestmann,Lukas Bestmann,Admar Verschoor,Mario Kreutzfeldt,Wolfgang Brück,Uwe-Karsten Hanisch,Stephan Günther,Daniel D. Pinschewer,Daniel D. Pinschewer +16 more
TL;DR: In this article, the authors found that T cell depletion in Lassa virus-infected HHD mice prevented disease, irrespective of high-level viremia, and the absence of extensive monocyte/macrophage activation in T cell-depleted mice suggested that T-cell responses contribute to deleterious innate inflammatory reactions and LF pathogenesis.